Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Experts See Rising Drug Prices Jeopardizing Health System

This article was originally published in PharmAsia News

Executive Summary

Experts on China report the country's health care system is in jeopardy because of soaring medical costs, including the price of drugs, which have gone unchecked for two decades. A report in the journal The Lancet attributed some of the costs to the price of medicines and treatments that in turn have caused hospitals to raise their prices to the point hospitalization can cost the annual income of some Chinese. The experts traced the rising costs faced by patients to a decline in state support for hospitals and doctors. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel